The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2019 | CyTOF flow cytometry in determining daratumumab response in myeloma
“Cytometry by Time of Flight (CyTOF) does not depend on the detection of fluorescence, but on the use of elemental metal isotopes conjugated to monoclonal antibodies. Francesca Gay, MD, PhD, University of Turin, Turin, Italy, discusses this platform, particularly its use in determining specific cellular mechanisms in the delevopment of treatment resistance, at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.
“
